 |
 |

Prevention of HIV InfectionLooking Back, Looking Ahead
Jeff Stryker;
Thomas J. Coates, PhD;
Pamela DeCarlo;
Katherine Haynes-Sanstad, MBA;
Mike Shriver;
Harvey J. Makadon, MD
JAMA. 1995;273(14):1143-1148.
Abstract
 |  |
For some, the occurrence of as many as 40 000 new human immunodeficiency virus (HIV) infections in the United States each year is evidence that HIV education and prevention efforts have failed. To the contrary, more than a decade of experience with HIV has demonstrated that lasting changes in behavior needed to avoid infection can occur as a result of carefully tailored, targeted, credible, and persistent HIV risk-reduction efforts. Given experience in other health behavior change endeavors, no interventions are likely to reduce the incidence of HIV infection to zero; indeed, insisting on too high a standard for HIV risk-reduction programs may actually undermine their effectiveness. A number of social, cultural, and attitudinal barriers continue to thwart the implementation of promising HIV risk-reduction programs. The remote prospects for a successful prophylactic vaccine for HIV and the difficulty in finding effective drug treatments have underscored the importance of sustained attention to HIV prevention and education. A series of "correlates of immunity" are identified— precedents that must exist to establish effective HIV prevention programs. These include sound policies promoting HIV risk reduction; access to health and social services, condoms, needles, and syringes; interventions shown to motivate behavioral change; organizations capable of reaching those at risk; and development and diffusion of technologies to interrupt the spread of the virus.
(JAMA. 1995;273:1143-1148)
Author Affiliations
From the Center for AIDS Prevention Studies (CAPS), Department of Medicine, University of California at San Francisco (Mr Stryker, Dr Coates, and Mss DeCarlo and Haynes-Sanstad); Mobilization Against AIDS, San Francisco, Calif (Mr Shriver); and the Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Mass (Dr Makadon).
Footnotes
Portions of this article were presented by Dr Coates at the Centers for Disease Control and Prevention as the keynote address for the Charles C. Shephard Award ceremonies.
Corresponding author: Jeff Stryker, Center for AIDS Prevention Studies (CAPS), Department of Medicine, University of California, San Francisco, 74 New Montgomery, Suite 600, San Francisco, CA 94105.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Randomized trial in family practice of a brief intervention to reduce STI risk in young adults
Proude et al.
Fam Pract 2004;21:537-544.
ABSTRACT
| FULL TEXT
Comprehensive STD/HIV Prevention Education Targeting US Adolescents: review of an ethical dilemma and proposed ethical framework
Brown and Simpson
Nurs Ethics 2000;7:339-349.
ABSTRACT
An Asymptomatic 41-Year-Old Man With HIV Infection
Makadon
JAMA 1999;281:739-744.
FULL TEXT
HIV Prevention in Clinical Practice
AIDS Clin Care 1999;1999:1-1.
FULL TEXT
Human Immunodeficiency Virus Sexual Risk Reduction in Homeless Men With Mental Illness
Susser et al.
Arch Gen Psychiatry 1998;55:266-272.
ABSTRACT
| FULL TEXT
HIV Prevention: Community Planning Groups
Holtgrave
JAMA 1995;274:1270-1270.
ABSTRACT
|